Diet, Exercise, and C-Reactive Protein Levels in People With Abdominal Obesity: The ATTICA Epidemiological Study
暂无分享,去创建一个
Undurti N. Das | Christodoulos Stefanadis | Demosthenes B. Panagiotakos | Christos Pitsavos | D. Panagiotakos | C. Stefanadis | C. Pitsavos | C. Chrysohoou | U. Das | Natalia Tzima | Yannis Lentzas | Christina Chrysohoou | Y. Lentzas | N. Tzima
[1] D. Mikhailidis,et al. The prevalence of the metabolic syndrome in Greece: The MetS‐Greece Multicentre Study , 2005, Diabetes, obesity & metabolism.
[2] S. Haffner,et al. The relation of body fat mass and distribution to markers of chronic inflammation , 2001, International Journal of Obesity.
[3] P. Ridker. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.
[4] Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. , 2004, Journal of the American College of Cardiology.
[5] Nancy R Cook,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.
[6] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[7] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[8] Boyd Swinburn,et al. Diet, nutrition and the prevention of chronic diseases. , 2003, World Health Organization technical report series.
[9] P. Ridker,et al. C-reactive protein and the risk of developing hypertension. , 2003, JAMA.
[10] J. Gauldie,et al. The acute phase response. , 1994, Immunology today.
[11] E. Rimm,et al. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. , 2004, Diabetes care.
[12] D. Panagiotakos,et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. , 2004, American heart journal.
[13] G. Reaven,et al. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.
[14] The Treatment of Coronary Heart Disease: An Update , 2001, Current medical research and opinion.
[15] B. Wisse,et al. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.
[16] D. Panagiotakos,et al. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study , 2003, BMC public health.
[17] D. Giugliano,et al. The metabolic syndrome and inflammation: association or causation? , 2004, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[18] S. Grundy. Inflammation, hypertension, and the metabolic syndrome. , 2003, JAMA.
[19] K. Shirai. Obesity as the core of the metabolic syndrome and the management of coronary heart disease , 2004, Current medical research and opinion.
[20] R. Marfella,et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. , 2004, JAMA.
[21] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[22] B. Nicklas,et al. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training , 2005, Canadian Medical Association Journal.
[23] Paul M. Ridker,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003 .
[24] J. Schneider,et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. , 2005, Diabetes care.
[25] A Trichopoulou,et al. Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. , 1997, International journal of epidemiology.
[26] M. Walker,et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. , 1995, The Journal of clinical endocrinology and metabolism.
[27] M. Joffres,et al. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys , 2001, International Journal of Obesity.
[28] Y. Sharabi,et al. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences , 2005, Expert review of cardiovascular therapy.
[29] N. Sattar,et al. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians , 2001, International Journal of Obesity.
[30] Ronald M. Krauss,et al. American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease , 1998 .
[31] Paul M. Ridker,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group , 2004 .
[32] J. Seward,et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. , 2005, American journal of hypertension.
[33] M. Raftery,et al. Oxidation of High Density Lipoproteins , 1998, The Journal of Biological Chemistry.